Home
RSS
Switzerland’s Roche said Thursday it has agreed to buy all the remaining shares in Genentech for $46.8 billion in a takeover described as the largest in Swiss corporate history.
Related Stories
Most Recent
Most Popular
Most Commented
1
Star It 
(0)
If you are looking to convert more visitors into customers on your site then check this video out…
made popular 18 hr. ago
A must read article for everyone - Find Your Purpose
I was going through this “not knowing your purpose” dilemma when I moved back from the States in early...
made popular 18 hr. ago
Brazil is proving to be the best alternative for national - and even foreign - companies to maintain their cash flows in the face of retracted global markets and of the...
made popular Jul 9 2009
I find that every body who thinks he is somebody has an opinion on budget. I consider myself to be no body still as self worth has no relation with net worth I also...
made popular Jul 9 2009
Xtremestartups team is excited to invite you to another edition of Startup Evening in Chandigarh on 11th July, 2009
Please Note: Xtremestartups event happens on the...
made popular Jul 9 2009
With his clean white university sweatshirt and shiny cellphone, Lee Chang-shik looks the part of a manager at a condominium development company, the job that he held...
made popular Jul 7 2009
* Vice minister sees dollar pre-eminence for years to come
* Idea of new reserve currency is ‘academic discussion’
* China appreciates U.S. govt efforts...
made popular Jul 7 2009
How they rip you off in the USA? As an MBA from a top business school in India I had been taught and accepted it as axiomatic that it was the American management...
made popular Jul 7 2009
While sending my answers to yourstory.in today, I came across a question - “Do you have any tips to share with budding entrepreneurs?”. I thought this might...
made popular Jul 1 2009
An advertising campaign for a hotel in Amsterdam has proved that honesty is the best policy. When brands are blowing their own trumpets by describing their unique and...
made popular Jun 30 2009
The world’s central bankers have warned that the British economy faces relapsing into another recession – the much-feared “double dip”...
made popular Jun 30 2009
The Financial Times reports that American television will face a $2 billion lose in advertising revenue over the next four years due to competing video mediums....
made popular Jun 30 2009
I am coming across more and more people who are just working for the sake of working - whether the work is paying them well or keeping them busy. It’s the same...
made popular Jun 30 2009
Yes. News bloopers do happen. Every year. Some are real. Some are fake ones created for attracting some free attention. If this video is fake, it is a kind of...
made popular Jun 29 2009
The Economist has succeeded to catch some curious glances through this billboard. By shooting some questions, the billboard leaves the viewer groping for answers. The...
made popular Jun 29 2009
Baci perugina, the chocolate brand in Italy, banks on love and romance to make it sweet and tempting. In its integrated campaign, the chocolate brand decided to sell...
made popular Jun 28 2009
Well-known high street furniture store Habitat has issued an apology (via its PR company, via a social media blog) for its misuse of popular hashtags on Twitter over...
made popular Jun 24 2009
The discussion around the Chris Anderson goof episode raises an interesting issue.
Is WordPress.com bad for the WordPress brand?
Think I am being to strong? Check out...
made popular Jun 24 2009
Tired of reading shocking headlines? Then, here is good news for you. Yes, good news, literally. Sears and AOL have launched GNN.com, which handles only feel good...
made popular Jun 24 2009
After the success of its first Startup event in Bangalore, Xtreme Startups team is excited to invite you to the 2nd edition of Startup Morning on 27th June, 2009 at...
made popular Jun 24 2009
All Stories
Most Recent
Most Popular
Most Commented
AP, Basel
Roche says it has agreed to buy the remaining shares of Genentech for $46.8 billion in what is being described as the largest takeover in Swiss corporate history.
made popular Mar 12 2009
AP, New York
Genentech’s board of directors is close to striking a $95-per-share deal to sell itself to cancer drug partner Roche, according to a report by the Wall Street...
made popular Mar 9 2009
AP, New York
Swiss drug developer Roche is boosting its hostile tender offer for biotechnology pioneer Genentech by 7.5 percent to $93 per share.
made popular Mar 6 2009
AP, New York
Genentech Inc. on Monday touted its culture of innovative research and offered detailed long-term sales projects as it made its case to Wall Street on what it considers...
made popular Mar 2 2009
AP, New York
Genentech Inc. says its shareholders should reject a hostile buyout bid from Swiss drugmaker Roche.
made popular Feb 23 2009
AP, Washington
Three patients taking a Genentech drug have died of a rare brain infection, a known risk with the skin-clearing treatment, according to federal health officials.
made popular Feb 19 2009
AP, New York
Roche’s hostile bid for Genentech Inc., which became official late Monday, revealed just how far apart the companies are on valuing Genentech, with the...
made popular Feb 10 2009
AP, New York
Swiss drugmaker Roche on Monday officially launched its $42 billion hostile offer for the 44 percent of Genentech Inc. it doesn’t already own.
made popular Feb 9 2009
AP, New York
Roche Chief Executive Severin Schwan said Friday the company’s surprisingly low hostile $86.50-per-share offer for biotech giant Genentech Inc. is fairly priced...
made popular Feb 6 2009
AP, Basel
Swiss pharmaceuticals company Roche Holding AG made a fresh bid to buy U.S.-based Genentech Inc. Friday by offering $86.50 per share _ $2.50 less than its previous...
made popular Jan 30 2009
AP, South San Francisco
Biotechnology company Genentech Inc.’s fourth-quarter profit fell short of Wall Street expectations, despite a 47 percent boost from higher sales of the...
made popular Jan 15 2009
AP, New York
Genentech says fourth-quarter profit rose 47 percent on a boost in sales of its key cancer drug Avastin, but the results and the 2009 outlook are shy of Wall Street...
made popular Jan 15 2009
AP, New York
The Food and Drug Administration said Thursday it will update the labeling of Genentech Inc.’s psoriasis drug Raptiva to highlight the risk of several bacterial...
made popular Oct 16 2008
AP, New York
In an Oct. 14 story about Genentech’s third-quarter results, The Associated Press erroneously reported financial forecasts by analysts surveyed by Thomson...
made popular Oct 16 2008
AP, New York
Genentech says its third-quarter profit rose 6.7 percent on rising sales of key cancer drugs, in line with Wall Street forecasts.
made popular Oct 14 2008
AP, Washington
Federal regualtors said Thursday one case of a deadly brain infection has been reported in a patient taking Genentech and Biogen Idec’s blockbuster arthritis and...
made popular Sep 11 2008
AP, New York
Biotechnology giant Genentech is turning down a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.
made popular Aug 13 2008
AP, San Francisco
Biotechnology pioneer Genentech Inc. mulled Roche Holding’s $43.7 billion offer for its remaining shares Monday as investors made clear their feelings that the...
made popular Jul 21 2008
AP, Geneva
Swiss drugmaker Roche on Monday offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech Inc. in a move to boost its stature in the market...
made popular Jul 21 2008
Related Tags
Avastin Basel Biotechnology Business earns EU Europe New York North America offer Pictorial Roche Roche Holding San Francisco south san francisco swiss Switzerland Technology United States Wall Street
Images
New York:
Severin Schwan, CEO of Roche, speaks during an interview with The Associated Press in this Friday, Feb. 6, 2009 file photo taken in New York. Roche announced Thursday March 12, 2009 it has agreed to buy the remaining shares of Genentech for $46.8...
